Trial Profile
A Randomised, Double-blind, Placebo-controlled Dose-escalation Phase I Study to Evaluate the Safety and Tolerability of Inhaled Aerosolised OligoG CF-5/20 (G-block Oligosaccharide Derived From Alginate Polysaccharide) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs OligoG (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions
- Sponsors AlgiPharma
- 11 Jun 2014 New trial record